Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 4
2007 1
2008 1
2009 1
2010 1
2012 1
2013 3
2014 5
2015 3
2016 5
2017 2
2019 3
2020 2
2021 4
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications.
Blache U, Weiss R, Boldt A, Kapinsky M, Blaudszun AR, Quaiser A, Pohl A, Miloud T, Burgaud M, Vucinic V, Platzbecker U, Sack U, Fricke S, Koehl U. Blache U, et al. Among authors: boldt a. Front Immunol. 2021 May 3;12:658314. doi: 10.3389/fimmu.2021.658314. eCollection 2021. Front Immunol. 2021. PMID: 34012442 Free PMC article.
Teclistamab impairs detection of BCMA CAR-T cells.
Glatte B, Wenk K, Grahnert A, Friedrich M, Merz M, Vucinic V, Fischer L, Reiche K, Alb M, Hudecek M, Franz P, Fricke S, Platzbecker U, Koehl U, Sack U, Boldt A, Hauschildt S, Weiss R. Glatte B, et al. Among authors: boldt a. Blood Adv. 2023 Aug 8;7(15):3842-3845. doi: 10.1182/bloodadvances.2023009714. Blood Adv. 2023. PMID: 37026812 Free PMC article. No abstract available.
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Fischer L, Grieb N, Born P, Weiss R, Seiffert S, Boldt A, Fricke S, Franz P, Heyn S, Kubasch AS, Baber R, Weidner H, Wang SY, Bach E, Hoffmann S, Ussmann J, Kirchberg J, Hell S, Schwind S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Sack U, Reiche K, Köhl U, Platzbecker U, Vucinic V, Merz M. Fischer L, et al. Among authors: boldt a. Leukemia. 2024 Feb;38(2):372-382. doi: 10.1038/s41375-023-02129-y. Epub 2024 Jan 6. Leukemia. 2024. PMID: 38184754 Free PMC article.
Antibody- and aptamer-strategies for GvHD prevention.
Oelkrug C, Sack U, Boldt A, Nascimento IC, Ulrich H, Fricke S. Oelkrug C, et al. Among authors: boldt a. J Cell Mol Med. 2015 Jan;19(1):11-20. doi: 10.1111/jcmm.12416. Epub 2014 Oct 29. J Cell Mol Med. 2015. PMID: 25353670 Free PMC article. Review.
Cellular analyses in the monitoring of autoimmune diseases.
Sack U, Boldt A, Mallouk N, Gruber R, Krenn V, Berger-Depincé AE, Conrad K, Tarnok A, Lambert C, Reinhold D, Fricke S. Sack U, et al. Among authors: boldt a. Autoimmun Rev. 2016 Sep;15(9):883-9. doi: 10.1016/j.autrev.2016.07.010. Epub 2016 Jul 5. Autoimmun Rev. 2016. PMID: 27392502 Review. No abstract available.
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Rade M, Grieb N, Weiss R, Sia J, Fischer L, Born P, Boldt A, Fricke S, Franz P, Scolnick J, Venkatraman L, Xu S, Kloetzer C, Heyn S, Kubasch AS, Baber R, Wang SY, Bach E, Hoffmann S, Ussmann J, Schetschorke B, Hell S, Schwind S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Sack U, Köhl U, Platzbecker U, Reiche K, Vucinic V, Merz M. Rade M, et al. Among authors: boldt a. Nat Cancer. 2024 Apr 19. doi: 10.1038/s43018-024-00763-8. Online ahead of print. Nat Cancer. 2024. PMID: 38641734
Novel diagnostic options for immunodeficiencies.
Sack U, Boldt A, Borte M, Borte S. Sack U, et al. Among authors: boldt a. Clin Biochem. 2014 Jun;47(9):724-5. doi: 10.1016/j.clinbiochem.2014.05.029. Epub 2014 May 20. Clin Biochem. 2014. PMID: 24854698 No abstract available.
45 results